Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peripheral Nervous System Diseases 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Vaso-Occlusive Crises 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oral Complications 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Malnutrition 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Leukemia 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Anemia, Sickle Cell 1

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Glutamine × Clear all
NCT00455247 2013-06-05

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

Société des Produits Nestlé (SPN)

Phase 3 Completed
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡